Future Planet Capital

Diverse School Travel is a UK-based small business specializing in organizing educational and cultural tours for schools and colleges. With its head office located in Birmingham, the company offers a range of exciting experiences across the UK, Europe, and beyond. The tours are designed to provide students with valuable learning opportunities in subjects such as history, modern languages, art, design, and geography, allowing them to engage with educational content in a stimulating environment outside the classroom. The team at Diverse School Travel is young, multi-lingual, and dedicated to delivering exceptional service and competitive pricing to ensure a memorable experience for all participants.

Midven, established in 1990 and headquartered in Birmingham, UK, is a venture capital firm specialising in early-stage and growth-stage investments. It focuses on providing up to £1 million to fast-growing small and medium-sized enterprises (SMEs), supporting their expansion and development. Midven's team, comprising experienced and hands-on investment managers, offers not only capital but also strategic guidance to its portfolio companies.

Linear Diagnostics Limited is a diagnostic technology company based in Birmingham, United Kingdom, founded in 2011. The company specializes in developing a novel diagnostic platform that utilizes linear dichroism (LD) to perform a wide range of molecular diagnostics tests. This technology allows for the rapid detection of multiple targets from a single sample, providing significant advantages over conventional methods. Linear Diagnostics focuses on various applications, including the detection of antibiotic resistance in infections and identifying bacteria responsible for food crop spoilage. Additionally, the company offers a handheld reader designed for measuring LD signals, enhancing the accessibility and efficiency of its diagnostic solutions. By addressing limitations associated with traditional detection techniques, Linear Diagnostics aims to improve healthcare outcomes and reduce costs.

Linear Diagnostics Limited is a diagnostic technology company based in Birmingham, United Kingdom, founded in 2011. The company specializes in developing a novel diagnostic platform that utilizes linear dichroism (LD) to perform a wide range of molecular diagnostics tests. This technology allows for the rapid detection of multiple targets from a single sample, providing significant advantages over conventional methods. Linear Diagnostics focuses on various applications, including the detection of antibiotic resistance in infections and identifying bacteria responsible for food crop spoilage. Additionally, the company offers a handheld reader designed for measuring LD signals, enhancing the accessibility and efficiency of its diagnostic solutions. By addressing limitations associated with traditional detection techniques, Linear Diagnostics aims to improve healthcare outcomes and reduce costs.

Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

Linear Diagnostics Limited is a diagnostic technology company based in Birmingham, United Kingdom, founded in 2011. The company specializes in developing a novel diagnostic platform that utilizes linear dichroism (LD) to perform a wide range of molecular diagnostics tests. This technology allows for the rapid detection of multiple targets from a single sample, providing significant advantages over conventional methods. Linear Diagnostics focuses on various applications, including the detection of antibiotic resistance in infections and identifying bacteria responsible for food crop spoilage. Additionally, the company offers a handheld reader designed for measuring LD signals, enhancing the accessibility and efficiency of its diagnostic solutions. By addressing limitations associated with traditional detection techniques, Linear Diagnostics aims to improve healthcare outcomes and reduce costs.

Diverse School Travel is a UK-based small business specializing in organizing educational and cultural tours for schools and colleges. With its head office located in Birmingham, the company offers a range of exciting experiences across the UK, Europe, and beyond. The tours are designed to provide students with valuable learning opportunities in subjects such as history, modern languages, art, design, and geography, allowing them to engage with educational content in a stimulating environment outside the classroom. The team at Diverse School Travel is young, multi-lingual, and dedicated to delivering exceptional service and competitive pricing to ensure a memorable experience for all participants.

Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

Diverse School Travel is a UK-based small business specializing in organizing educational and cultural tours for schools and colleges. With its head office located in Birmingham, the company offers a range of exciting experiences across the UK, Europe, and beyond. The tours are designed to provide students with valuable learning opportunities in subjects such as history, modern languages, art, design, and geography, allowing them to engage with educational content in a stimulating environment outside the classroom. The team at Diverse School Travel is young, multi-lingual, and dedicated to delivering exceptional service and competitive pricing to ensure a memorable experience for all participants.

Etive Technologies Limited specializes in providing digital data handling solutions focused on personal and property information through a range of web-based log book products. The company's offerings include the Digital Log Book, which helps individuals create a digital identity, and the Home Log Book, designed to enhance the buying process for new home developers by providing essential information and improving post-occupancy customer service. Additionally, the Energy Log Book allows users to monitor and manage home energy consumption. Etive serves a diverse clientele, including local authorities, housing associations, new home builders, healthcare providers, financial service companies, and estate agencies. Founded in 2011 and based in Edinburgh, with an additional office in Birmingham, the company was previously known as Home Log Book Solutions Limited before rebranding in December 2013.

Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

Diverse School Travel is a UK-based small business specializing in organizing educational and cultural tours for schools and colleges. With its head office located in Birmingham, the company offers a range of exciting experiences across the UK, Europe, and beyond. The tours are designed to provide students with valuable learning opportunities in subjects such as history, modern languages, art, design, and geography, allowing them to engage with educational content in a stimulating environment outside the classroom. The team at Diverse School Travel is young, multi-lingual, and dedicated to delivering exceptional service and competitive pricing to ensure a memorable experience for all participants.

Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.